Marso, S. P. Et Al. 2016. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.. The New England journal of medicine , vol.375, no.4 , 311-22.

Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., ... Nissen, S. E.(2016). Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.. The New England journal of medicine , vol.375, no.4, 311-22.

Marso, Steven Et Al. "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.," The New England journal of medicine , vol.375, no.4, 311-22, 2016

Marso, Steven P. Et Al. "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.." The New England journal of medicine , vol.375, no.4, pp.311-22, 2016

Marso, S. P. Et Al. (2016) . "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.." The New England journal of medicine , vol.375, no.4, pp.311-22.

@article{article, author={Steven P Marso Et Al. }, title={Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.}, journal={The New England journal of medicine}, year=2016, pages={311-22} }